ACT-1014-6470
ACT-1014-6470 is an orally active, potent, reversible, and selective C5aR1 antagonist. ACT-1014-6470 demonstrates potent inhibition of C5aR1 activation. ACT-1014-6470 can be used in the research of inflammatory diseases[1][2].
Product Specifications
CAS Number
2363082-87-3
UNSPSC
12352005
Target
Complement System
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C1N(CC2=CC=CC=C2C(F)(F)F)C3=NN(CC(F)(F)C)C=C3CN1C4CCN(C5=C(C)C=CC=C5F)CC4
Molecular Formula
C28H29F6N5O
Molecular Weight
565.55
References & Citations
[1]Sylvie FROIDEVAUX, et al. 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases. WO2019137927A1. WIPO (PCT) . 2019-01-09. |[2]Ort M, et al. First-in-human study with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients. Basic Clin Pharmacol Toxicol. 2022 Aug;131 (2) :114-128.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0031362 96 Tests
Multiplex Assay Kit for Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1), etc. by FLIA (Flow Luminescence Immunoassay)
Sign In for Pricing
View Details ![Human Monoclonal CD25/IL-2R alpha Antibody (Hu107) [DyLight 350]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
FAB9926D 0.1 mL
Human Monoclonal CD25/IL-2R alpha Antibody (Hu107) [DyLight 350]
Sign In for Pricing
View Details LS009538-100ug 100 µg
EI24 (NM_004879) Human Over-expression Lysate
Sign In for Pricing
View Details 
K0288705 3x 1.0 µg
C12orf5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details